Dr. Woodard’s expertise is in translational imaging and clinical trials, particularly in cardiovascular MRI, CT and PET. She is Radiology’s Vice Chair of Clinical Translational Research, has an appointment in Biomedical Engineering and is the Director of the Center for Clinical Imaging Research (CCIR). She has been principal investigator (PI) or co-investigator on numerous NIH grants and subcontracts, including the PIOPED II and III Trials. Most recently, her lab has developed a receptor-targeted nanoparticle PET imaging agent for assessment of atherosclerosis, brought it through preclinical safety testing, applied for and received an FDA eIND for testing in human subjects, and have begun testing in normal volunteers and patients. New extensions of the same receptor targeted nanoparticle include optical labelling for imaging with fluorescence molecular tomography.